As Frances Tiafoe continues to rack up milestones on the tennis court, one steady presence has remained by his side through it all: his longtime girlfriend, Ayan Broomfield.

Tiafoe, who reached the US Open semifinals for the third time in his career this September, has been with Broomfield for more than a decade. The couple’s relationship, which began in 2015, has evolved alongside both of their careers — his rise through the ranks of professional men’s tennis, and hers from college tennis standout to entrepreneur and advocate for diversity in the sport.

A Canadian upbringing and a path through college tennis

Broomfield was born Aug. 13, 1997, in Ontario, Canada, and spent her childhood there before moving to the United States to pursue tennis at the collegiate level. She began her college career at Clemson University, where she was named ACC Freshman of the Year and honored as the ITA Carolina Region Rookie of the Year.

After two seasons at Clemson, Broomfield transferred to UCLA, a move she has described as driven by the program’s tradition and the opportunity to help shape its future. The decision paid off. During her senior year, Broomfield and doubles partner Gabby Andrews won the 2019 NCAA doubles championship, marking UCLA’s seventh NCAA doubles title in program history.

“My number one goal for college tennis was to get a national championship ring. look what just arrived,” Broomfield wrote on Instagram at the time, “could not be happier to get it while competing at ucla.”

A brief run on the professional tour

Before enrolling at Clemson, Broomfield made her WTA debut in 2014 at the Coupe Banque Nationale, competing in doubles alongside partner Maria Patrascu. The pairing reached a career-high ranking of No. 467 in the world. She later shifted her focus toward singles competition and, since stepping away from professional play, has built partnerships with brands including Wilson and Athleta.

Her tennis background also opened an unexpected door into film. Broomfield served as a body double for actress Saniyya Sidney, who portrayed Venus Williams in the 2021 film “King Richard.” While on set, she crossed paths with Will Smith and Serena Williams. Tiafoe accompanied Broomfield to the film’s premiere that November, later writing on Instagram, “I couldn’t be happier we was able to experience such a iconic night together.”

How the relationship began

Tiafoe and Broomfield were introduced through a mutual friend and fellow tennis player, Victoria Duval, a story Tiafoe recounted during an August 2018 press conference.

“You know, Instagram these days and, you know, I slid in her DMs,” Tiafoe said. “And then it was quite weird. I don’t usually do it, and we started talking a little bit, and then I asked for her number.”

Their connection moved quickly. Broomfield and her family attended the 2015 US Open to watch Tiafoe compete, a moment he later reflected on with some amusement. “I was like, jeez, we’re not even dating yet, and I’m already meeting your family,” Tiafoe said. “We’re moving quite quick here, but that was another story.”

The couple officially began dating on Sept. 8, 2015, and made their relationship Instagram official three months later, in December of that year.

A partnership built on mutual understanding

Speaking to the ATP in August 2023, Broomfield described how she and Tiafoe complement each other despite differing temperaments, characterizing him as naturally “happy-go-lucky” while she tends toward a more serious disposition. “I think we balance each other out a lot,” she said.

Broomfield’s own tennis background has also made her a trusted sounding board for Tiafoe as his career has progressed. “We can talk about tennis. I mean, I played tennis myself,” she said. “So even just when we’re seeing the draw, and we kind of look at certain players, sometimes I can act as a sounding board for matches.” She added that even when Tiafoe doesn’t follow her advice, the shared frame of reference matters: “I just feel like we just understand it and what it takes for someone to go and be able to compete at the highest level.”

Tiafoe has been similarly vocal about Broomfield’s importance in his life, particularly around career milestones. When he first cracked the top 10 in the world rankings in June 2023, Broomfield marked the occasion with a series of screenshots documenting his progress over the years, writing on Instagram, “I started taking screenshots of different moments and accomplishments a few years ago in anticipation of this day … I am so proud of you.” Tiafoe responded in the comments, writing in part, “Man to think how far we’ve come. 2015 meeting you for the first and also just starting my career. Youve rocked with me thru it all.”

That same year, Broomfield surprised Tiafoe by attending his match at the Fayez Sarofim & Co. U.S. Men’s Clay Court Championship without his knowledge. He didn’t realize she was in the stands until the end of the first set. “I also want to thank … my girlfriend Ayan, who I see in the crowd at 1-0. I didn’t even know you were in Houston. I thought you were in L.A.! She surprised me, that’s unbelievable you’re here,” Tiafoe said during his post-match victory speech.

Championing representation in tennis

Beyond her support for Tiafoe’s career, Broomfield has built her own platform within the sport. In early 2025, she launched Ayan’s Aces, an initiative focused on increasing diversity within tennis. The program’s inaugural event brought together more than 100 women of color at the Miami Open.

Since then, Broomfield has continued expanding the initiative’s reach, working to elevate representation for women of color both in stadium suites and at cultural events surrounding professional tennis tournaments. As Tiafoe’s on-court success continues to draw attention, Broomfield’s off-court advocacy work has increasingly become part of the story surrounding one of American tennis’ most recognizable couples.

Janus Henderson Investors exists to help clients achieve their long-term financial goals. Formed in 2017 from the merger between Janus Capital Group and Henderson Global Investors, we are committed to adding value through active management. For us, active is more than our investment approach – it is the way we translate ideas into action, how we communicate our views and the partnerships we build in order to create the best outcomes for clients. While our investment managers have the flexibility to follow approaches best suited to their areas of expertise, overall our people come together as a team. This is reflected in our Knowledge. Shared ethos, which informs the dialogue across the business and drives our commitment to empowering clients to make better investment and business decisions.www.janushenderson.com

Kuwait International Airport remains open and operating flights today, continuing months of restricted but functional service that has followed a series of Iranian attacks on the facility earlier this year during the broader regional conflict involving Iran, the United States and Israel.

The airport, commonly known by its code KWI, is running operations through two active passenger terminals — Terminal 4 and Terminal 5 — while Terminal 1 remains closed for repairs following direct damage sustained during Iranian drone and missile strikes. Kuwait Airways operates out of Terminal 4, while Jazeera Airways uses Terminal 5, alongside a growing number of returning international carriers, according to travel-advisory trackers monitoring the airport’s operations throughout the year.

A year of disruption traced to February

The disruptions affecting Kuwait’s main airport trace back to Feb. 28, when Iran launched “Operation True Promise IV” in response to Israeli and American strikes under operations known as Roaring Lion and Epic Fury. The Iranian campaign targeted regional states hosting U.S. military assets, including Bahrain’s Navy 5th Fleet, the United Arab Emirates’ Dhafra Airbase and Qatar’s Al-Udeid Airbase. Kuwait International Airport was targeted as a logistics hub tied to coalition transport, and Kuwaiti airspace shut down entirely on the first day of the conflict alongside other airspaces in the region.

In the weeks that followed, the airport sustained repeated damage. A drone strike hit Terminal 1, causing minor injuries to several employees and structural damage to the building, according to Kuwait’s Directorate General of Civil Aviation. On March 8, a wave of drones and missiles targeted the airport again, igniting a large fire in one of its fuel storage tanks. Four days later, on March 12, another strike caused material damage near the site, severing several power lines when struck by drone debris. By the night of March 14, the DGCA reported that drones had struck the airport’s primary surveillance radar system.

The intensity of the campaign forced a total suspension of commercial aviation in Kuwaiti airspace for a period, with local carriers such as Jazeera Airways diverting operations to Qaisumah International Airport in Saudi Arabia, roughly a two-and-a-half-hour drive from Kuwait. At the height of the conflict, Kuwait’s national carriers were at times forced to reroute flights entirely through Dammam’s King Fahd International Airport in Saudi Arabia, requiring passengers to complete lengthy bus transfers to reach their actual flights. Most operations have since returned directly to Kuwait.

A brief closure in June, then reopening

The airport also faced a precautionary shutdown in June, when Iran launched renewed drone and missile attacks on Kuwait as part of the wider conflict. One person was killed and a dozen others were injured in the resulting violence, and flights headed toward Kuwait were rerouted to destinations including Doha, Dubai and Riyadh. Kuwait’s DGCA reopened the airport the following day, announcing on social media the “return of air traffic in Kuwaiti airspace to normal” while noting that authorities were “closely monitoring the situation around the clock in continuous coordination with relevant authorities inside and outside the State of Kuwait, to ensure the highest levels of safety and security in the airspace.”

Current conditions: open, but not normal

Despite the repeated disruptions, Kuwait International Airport has generally returned to functional operations between incidents throughout the year, according to multiple travel-advisory trackers, with its two active terminals handling both domestic carriers and a growing list of returning international airlines, including Emirates, flydubai, Air Arabia and Oman Air.

Kuwaiti airspace is currently open for arrivals and departures, but it remains closed to overflights, and each arrival and departure requires prior approval from authorities. That arrangement continues to produce day-to-day delays, and travel trackers advise passengers to treat departure times as provisional until confirmed directly by the airline. Kuwait Airways is currently flying out of Terminal 4 to destinations across Europe, Turkey, India and the Gulf, with routes in early September including Paris, Munich, Istanbul, Mykonos and Lahore outbound, and Delhi and Kochi inbound.

The European Union Aviation Safety Agency has issued a conflict-zone advisory recommending that operators avoid the Kuwaiti flight information region entirely at any altitude, citing renewed military activity following the breakdown of a U.S.-Iran ceasefire in July and continued attacks around the Strait of Hormuz. According to OPSGROUP, an organization that tracks international airspace risk, Kuwait remains closed to overflights until at least Oct. 2, with only flights arriving at or departing from Kuwait allowed, subject to prior approval.

The U.S. Embassy in Kuwait has maintained a Level 3 travel advisory urging Americans to “reconsider travel” to the country, with no recent change to that risk level. In a security alert issued this month, the embassy advised Americans traveling to or from the region to “monitor information about airport and airline operations,” warning that Iran and allied groups “may target other U.S. interests overseas or at locations associated with the United States and Americans throughout the world.”

Rebuilding and expansion continue

Separate from the immediate repair effort at Terminal 1, Kuwait has continued advancing a long-planned expansion of its aviation infrastructure. A new Terminal 2, designed by the architecture firm Foster + Partners, is expected to become operational in the final quarter of the year, according to DGCA officials. The expansion is intended to significantly boost the airport’s passenger handling capacity, from roughly 16 million passengers annually to an estimated 25 million, with a maximum design capacity of 27 million. Officials have also highlighted an adjoining Air Cargo City facility, described as one of the largest cargo hubs in the Middle East and capable of accommodating more than 77 large cargo aircraft.

The DGCA has undertaken 13 major infrastructure projects tied to the airport’s modernization, including reconstruction of its central and eastern runways, which officials say will become operational following full activation of a third runway in the coming period.

For now, travelers flying in or out of Kuwait are advised to reconfirm their routes directly with airlines, particularly if tickets were booked months in advance, as the network has been rebuilt in phases since the conflict began. Delays remain frequent even as outright cancellations have become less common, reflecting an airport that is functioning but still operating under the shadow of an active regional conflict.

For Gerald Gan, chief investment officer at the Singapore-based firm, it was an easy call. “There isn’t much going on for a good India story,” Gan said. “It is more the growth story that is withering away for India.”

Gan’s views echo the growing skepticism toward Indian equities among a section of global money managers, who cite the absence of an artificial-intelligence investment theme and lukewarm corporate earnings as reasons to either cut their allocations or completely exit the $5.1 trillion market. As a result, foreign portfolio ownership of companies listed on the National Stock Exchange of India Ltd. has tumbled to a 17-year low.

Bloomberg

The retreat marks a stark reversal for a market that was one of the world’s hottest investment destinations not long ago. India now ranks the least-favored market in Asia, according to a recent Bank of America investor survey. Money managers at Janus Henderson Investors and Vantage Point Asset Management said the funds have pared India exposure to zero in the past year or so.
Whereas India’s economic growth rate — one of the highest globally — and Prime Minister Narendra Modi’s infrastructure build-out were the key attractions just a few years ago, that promise pales beside the returns generated from AI plays in South Korea and Taiwan.

Live Events

Indian equities trade at about 17.6 times forward earnings — slightly below their historic average — but still remain significantly more expensive than their emerging market peers. The NSE Nifty 50 Index still commands a 77% valuation premium to MSCI Inc.’s emerging-market benchmark, prompting foreign funds to pull about net $25 billion this year and deploy it elsewhere.
That’s left the Nifty 50 Index languishing near its mid-2024 level. It is on track to snap a decade-long streak of annual gains — a run bettered among major global equity markets only by Japan’s Nikkei 225 in the 1980s.

Bloomberg

“Many wealth managers have taken India back to underweight or completely out as they are more concerned about covering the increased weighting of tech plays in Taiwan and South Korea,” said Dubai-based Global CIO Office Chief Executive Gary Dugan. “They don’t see the same kind of risk of missing out in India given the headwind of a high oil price and weak currency.”

About 30% of Global CIO Office’s clients, which include family offices and wealth managers, have exited India entirely, Dugan said.

Still, local institutions have provided a floor for the market, with net stock purchases of about $60 billion this year, according to BSE Ltd. data. The buying has helped small-cap stocks in the country emerge as a bright spot, buoyed by companies benefiting from India’s data center build-out.

Morgan Stanley says India is in the midst of a multi-quarter growth upcycle, and given the supportive equity valuations, market performance should improve in the months ahead. The brokerage sees the BSE Sensex Index rising 19% to 89,000 by June next year in its base-case scenario, and reaching 100,000 in a bull case.

Yet investors are becoming more discerning. NSE — the poster child of India’s financialization boom — was forced to downsize its long-awaited initial public offering this week after investors pushed back against valuations.

‘Real Issue’

After more than 12 years in power, Modi has struggled to translate India’s status as the world’s fastest-growing major economy into an attractive market for foreigners. The old structural bull case of a large consumer and services market is now being challenged by a lack of meaningful AI play and the high dependence on oil imports.

More than ever, India is in need of foreign capital, especially more durable foreign direct investments that can fuel Modi’s manufacturing ambitions and provide a buffer against fickle portfolio flows. Fund managers now say the leader needs to do more to lure back foreign investors.

“Modi came in. He did some positive things that were done very well and within a reasonable timeframe, such as GST harmonization, the real estate reform, the bankruptcy court, but that hasn’t solved the real issue,” said Sat Duhra, a portfolio manager at Janus Henderson Investors. “The issue is jobs, it’s trying to build manufacturing, trying to gain the FDI.”

Bloomberg

Indian assets’ vulnerability to swings in oil prices came to the fore with the outbreak of the US-Iran war. Alongside the stock-market decline, the rupee slumped to a record low and continues to rank among Asia’s worst performers this year despite India raising $127 billion from its diaspora to bolster its currency defenses.

“The result has been pressure on the current account balance and a weaker rupee. Currency depreciation can compound foreign investors’ concerns as it erodes dollar returns, tightens local financial conditions at the margin, and raises questions about the durability of corporate margins,” said Carlos Casanova, senior economist for Asia at Union Bancaire Privee.

Complicating matters is India’s shrinking clout in emerging-market indexes, driven by its poor performance versus AI-focused North Asian markets. The South Asian nation now accounts for about 11% of the MSCI Emerging Markets Index, down from 16% a year ago, according to data compiled by Bloomberg.

“India’s relative underperformance reduces its index weight, which then gives benchmark-conscious managers less reason to own it, adding to the selling pressure,” Dugan said. “But it is also an indicator of the times. The dominant theme in emerging markets at the moment is tech, and that is where the money is going.”

Asked about President Donald Trump’s proposal to dole out $5,000 to every adult American if Republicans win both chambers of Congress during the midterm elections, Florida Gov. Ron DeSantis warned that borrowing to spend would cause more inflation.

“What I would say is, if you are getting surplus revenue, you should cut people’s tax and return it to the people,” DeSantis said on Thursday. “What I don’t think you wanna do is borrow another … trillion and a half dollars and then just try to flood that into the economy, because that will lead to more inflation. That will lead to more debt,” he said, “and more inflation.”

With the election on the horizon, President Donald Trump declared during remarks at the Republicans’ midterm convention on Wednesday that “because of our tremendous strength and success economically, I will issue a dividend to every adult citizen in the United States of America for $5,000” if the GOP wins the House and Senate.

TRUMP’S $5,000 DIVIDEND PROPOSAL COULD ADD $1.2T TO FEDERAL DEFICIT, ANALYSTS SAY

Florida Gov. Ron DeSantis delivers his State of the State address during the first day of the legislative session at the Florida State Capitol on Tuesday, Jan. 13, 2026, in Tallahassee, Fla. (Matias J. Ocner/Miami Herald/Tribune News Service via Getty Images / Getty Images)

“The only caveat I have is that the dividend that we’re making must be spent in the United States of America,” Trump said. “So if the Republicans win, you win with us and you get $5,000. It will be called the Trump dividend,” he declared.

The U.S. national debt recently surpassed the $40 trillion mark.

AMERICA’S $40T NATIONAL DEBT IS ‘STEALING FROM OUR NEXT GENERATION,’ ECONOMIST WARNS

DeSantis noted that it is becoming increasingly costly to service the U.S. national debt, predicting that the issue will “lead … to some upheavals, unfortunately,” adding, “I hope I’m wrong.”

The governor advocated for a Constitutional amendment to require a balanced federal budget.

‘NONE OF THE GOVERNMENT’S DAMN BUSINESS’: DESANTIS PUSHES BACK ON HIGHWAY SURVEILLANCE

GET FOX BUSINESS ON THE GO BY CLICKING HERE

“But the way it works now in Congress, their incentives are to add debt for short-term political benefit,” DeSantis said. “They never have to make tough decisions.”

Fox News Digital reached out to the White House for comment on Friday.

When results from a British clinical trial of a repurposed diabetes drug reached a leading medical journal in December 2025, the finding carried a quiet backstory about who pays for early science.

The study suggested that liraglutide could slow cognitive decline and brain shrinkage in people with mild Alzheimer’s disease. Years before those headlines appeared, the philanthropic record of Sir Evelyn de Rothschild had already touched this field through the family foundation he built around medical research. His giving offers a useful case study in how private capital underwrites experimental work long before any result is certain, and in how a single grant can travel a long way from the donor who signs it.

A trial that put an old drug to a new test

The trial, known as ELAD, tested liraglutide, a compound first developed for type 2 diabetes and obesity. Researchers recruited 204 participants with mild to moderate Alzheimer’s across two dozen clinics in the United Kingdom, giving half a daily injection and half a placebo over the course of a year. Professor Paul Edison of Imperial College London led the work, and the team reported that patients on the drug held on to more brain volume and showed slower cognitive decline than those on placebo.

The group, working on a phase 2b study coordinated at Imperial College London, presented its main findings at a major dementia conference in 2024, with the full paper appearing in the journal Nature Medicine the following year. Edison framed the outcome in plain terms, telling reporters that liraglutide appeared to be “protecting the brain, much like statins protect the heart.” The comparison signaled cautious optimism rather than a cure. The drug belongs to a class of medicines now studied for their effects on the brain, and the ELAD result added weight to the idea that metabolic pathways matter in dementia.

A funding chain that started with private giving

Trials of this kind rarely happen without patient funders willing to back unproven ideas. Edison secured support from three sources: a British dementia charity, a pharmaceutical company, and a New York nonprofit that specializes in early-stage drug work. That nonprofit, the Alzheimer’s Drug Discovery Foundation, operates on a venture-philanthropy model, channeling donations into projects that traditional funders often pass over.

The connection to Sir Evelyn de Rothschild runs through that foundation. Grant records of the charitable foundation he established in 1967 show sustained support for the Alzheimer’s Drug Discovery Foundation across several years, including a grant earmarked for the liraglutide clinical trial at Imperial College London. The relationship spanned multiple awards through the 2010s, part of a broader pattern of medical-research giving that the Foundation has maintained since its earliest days.

The arrangement illustrates a layered model of philanthropy. Money moves from a family foundation to a specialist grantmaker, then to a university laboratory, and finally into a trial that may or may not succeed. Each link in that chain absorbs some uncertainty so the science can proceed, and each keeps the original donor several steps removed from the eventual result.

A disease that outpaces its treatments

The urgency behind this funding reflects the scale of the disease. The World Health Organization estimates that more than 55 million people live with dementia worldwide, with Alzheimer’s accounting for most cases, and that figure is projected to climb as populations age. Care costs run into the hundreds of billions of dollars each year, borne by families and health systems alike.

Progress on treatment has been slow and uneven. For years, drug candidates failed in late-stage trials, and approved therapies have delivered modest benefits. That record makes patient, diversified funding valuable, because it spreads support across many approaches rather than concentrating on one. A repurposed diabetes drug, a mitochondrial molecule, and an antibody therapy each represent a separate route toward the same goal.

Philanthropic money has a particular use in this setting. It can move quickly, tolerate failure, and support ideas that lack an obvious commercial path. The medical grantmaking associated with Sir Evelyn de Rothschild sat squarely in that space, funding questions rather than products and accepting that answers would arrive slowly, if at all.

Targeting the cell’s power supply

The Foundation’s interest in dementia science extended beyond a single drug. Its medical grants have reached laboratories studying the biology of the disease itself, including work on how brain cells produce and manage energy. At Mayo Clinic in Minnesota, researcher Eugenia Trushina has spent years investigating mitochondria, the structures that power neurons, and their part in the earliest stages of Alzheimer’s.

Her laboratory at Mayo Clinic has focused on a component of cellular energy production called complex I, and on small molecules that can adjust its function to protect brain cells. The approach differs from the amyloid-focused strategies that dominated dementia research for decades, and it reflects a growing view that metabolic breakdown appears early, sometimes before memory loss begins.

Support for this line of inquiry fits the pattern of Sir Evelyn de Rothschild’s medical philanthropy, which favored fundamental questions over quick wins. Grantmaking of this type accepts that many projects will never produce a marketed therapy. The payoff, when it comes, tends to arrive as knowledge that shapes the next generation of experiments rather than as an immediate cure.

A foundation built for the long horizon

Sir Evelyn de Rothschild created his foundation in 1967, giving it a name his father had coined from the names of his three children. The Foundation grew into one of the larger charitable trusts in Britain, distributing roughly four to five million pounds each year across medicine, education, social welfare, and the arts. Its own description of its work lists cutting-edge research into Alzheimer’s alongside economics and the arts, a signal of how central medical science became to its mission.

Health giving formed a durable thread through that record. The Foundation backed a children’s hospital nursing scholarship, hospice care, and cancer support services, in addition to the dementia research described here. The banker who directed much of this work, Sir Evelyn de Rothschild, approached charity with the same long view he brought to finance, where he led the family bank for nearly three decades. That temperament suited medical research, a field measured in decades rather than quarters.

The pattern also shows up in how the Foundation spread its medical support. Rather than concentrate on one institution or one condition, it funded clinical trials, laboratory science, and patient care across separate centers and countries. That spread mirrors the logic of a diversified portfolio, where the aim is to keep several promising bets alive at once. Applied to health research, the method reflects a recognition that no single laboratory holds the answer, and that progress usually emerges from many independent efforts pursued in parallel.

Why early money matters

The liraglutide result did not settle the question of how to treat Alzheimer’s. It offered a signal, one data point among many, that a familiar drug might slow the disease. Larger studies will test whether the effect holds. That uncertainty is the point of early philanthropy, which exists to fund the stage at which no one yet knows the answer.

Sir Evelyn de Rothschild died in 2022, and the foundation he shaped continues its grantmaking under the family’s direction. The science it helped support moves forward on its own timeline, through trials, laboratories, and journals far removed from the world of banking. The connection between a private foundation and a peer-reviewed dementia study is easy to miss, yet it captures something durable about how research gets funded. Discovery of this kind depends on donors willing to wait.